News
Craig-Hallum Maintains Buy on DiaMedica Therapeutics, Lowers Price Target to $8
21 Mar 24
News, Price Target, Analyst Ratings
Oppenheimer Reiterates Outperform on DiaMedica Therapeutics, Lowers Price Target to $6
21 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Recap: DiaMedica Therapeutics Q4 Earnings
19 Mar 24
Earnings
DiaMedica Therapeutics FY23 EPS $(0.60) Vs $(0.52) YoY; $53M Cash With Runway To 2026
19 Mar 24
Earnings, News